✦ LIBER ✦

ALK-positive non-small cell lung cancer: Mechanisms of resistance and emerging treatment options

✍ Scribed by Steuer, Conor E.; Ramalingam, Suresh S.

Book ID: 121855101
Publisher: John Wiley and Sons
Year: 2014
Tongue: English
Weight: 399 KB
Volume: 120
Category: Article
ISSN: 0008-543X
DOI: 10.1002/cncr.28597

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Crizotinib: A New Treatment Option for A

Crizotinib: A New Treatment Option for ALK-Positive Non-Small Cell Lung Cancer

✍ O'Bryant, C. L.; Wenger, S. D.; Kim, M.; Thompson, L. A. 📂 Article 📅 2013 🏛 Harvey Whitney Books Company 🌐 English ⚖ 192 KB

The biology and treatment of EML4-ALK no

The biology and treatment of EML4-ALK non-small cell lung cancer

✍ Takaaki Sasaki; Scott J. Rodig; Lucian R. Chirieac; Pasi A. Jänne 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 671 KB

Targeting ALK in patients with advanced

Targeting ALK in patients with advanced Non Small Cell Lung Cancer: Biology, diagnostic and therapeutic options

✍ Lazzari, Chiara; Spitaleri, Gianluca; Catania, Chiara; Barberis, Massimo; Nobera 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 685 KB

Cost Effectiveness of EML4-ALK Fusion Te

Cost Effectiveness of EML4-ALK Fusion Testing and First-Line Crizotinib Treatment for Patients With Advanced ALK-Positive Non-Small-Cell Lung Cancer

✍ Djalalov, S.; Beca, J.; Hoch, J. S.; Krahn, M.; Tsao, M.-S.; Cutz, J.-C.; Leighl 📂 Article 📅 2014 🏛 American Society of Clinical Oncology 🌐 English ⚖ 306 KB

Budget Impact Of Crizotinib For Alk-Posi

Budget Impact Of Crizotinib For Alk-Positive Advanced Non-Small Cell Lung Cancer (Nsclc) In Colombia

✍ Rosado-Buzzo, A.; Garcia-Mollinedo, L.; Luna-Casas, G.; Mould-Quevedo, J.F.; Gut 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB

Non-Small-Cell Lung Cancer in Elderly Pa

Non-Small-Cell Lung Cancer in Elderly Patients: A Discussion of Treatment Options

✍ Gajra, A.; Jatoi, A. 📂 Article 📅 2014 🏛 American Society of Clinical Oncology 🌐 English ⚖ 178 KB